436
Participants
Start Date
October 1, 2018
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2026
BMT+TEVAR
These FDA-approved devices will be used for performing TEVAR in the patients randomized to this arm, in addition to the medical therapy to control blood pressure (BMT)
BMT
Optimal medical therapy will be administered to the patients randomized to this arm, involving but not limited to, beta-blockers, etc., to control the blood pressure and pain for stabilizing the patient upon presentation.
RECRUITING
Department of Cardiothoracic and Vascular Surgery and Memorial Hermann Heart and Vascular Institute - Texas Medical Center, Houston
RECRUITING
Department of Cardiothoracic and Vascular Surgery; Memorial Hermann Hospital Southeast, Houston
The University of Texas Health Science Center, Houston
OTHER